ClinicalTrials.gg
RecruitingNCT06519253Updated Jul 25, 2024

Virtual Reality Music in Geriatric Inpatients

An interventional study of Virtual reality (VR) music intervention and Music only control in Older Adult and Hospitalization, sponsored by St. Mary's Research Center, Canada. Recruiting at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by St. Mary's Research Center, Canada · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Older adults, especially those in acute care require accessible non-pharmacological interventions, such as music to improve their mental health. Immersive 360 virtual reality (VR), is an innovative technology that has been found to be feasible, safe, and enjoyable by older adults. However, VR based music intervention to improve older adults' mental health has not been studied in acute in-patient settings.

02

Conditions studied

  • Older Adult
  • Hospitalization
03

In context

Lead sponsor

St. Mary's Research Center, Canada is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of 60 years or older;
  • Medical stability to participate in the trial as determined by treating physician (defined as stable vital signs, absence of new medical events and deteriorating signs),
  • Admitted to the GAU (5 north) at St. Mary's hospital.

Exclusion criteria

Exclusion Criteria:

  • Medical instability which limits ability to participate in the study (unstable vital signs, delirium, new medical events, deteriorating signs),
  • Unablility to communicate in English or French,
  • Behavioural issues/delirium that limit participation in the study,
  • Those who have very severe dementia (using the Reisberg stage 7 which is defined by very limited communication ability, and dependence for all self-care
  • Those without sufficient auditory acuity to undergo assessment and participate in the intervention, which affects their ability to communicate their consent for this study and to listen to music
  • Ophthalmological conditions which affects their ability to participate in the immersive VR (recent eye surgery, severe macular degeneration, severe glaucoma, epilepsy and seizures, etc.).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    VR Music- Intervention

    Treatment Group: music intervention via virtual reality (VR) The music intervention aims to reproduce the experience of a musical performance. During the intervention, the participants will wear a VR headset which will give them an immersive experience of attending a virtual performance. During the intervention, the participants will be able to see the musicians (and the stage, empty auditorium, etc.) and hear the music. The participants in the VR intervention will be seated during the 15 minutes of intervention and the research assistant will stay at their side during the entire intervention. There will be no hand-help components to the VR intervention. Should the participant express any discomfort or have any questions/concerns with the intervention, the research assistant will be available and able to answer/assist the participants.

    Other: Virtual reality (VR) music intervention

  • Active comparator
    Music- Active Control

    The participants in the active control group will listen, via a headband, the same music as the VR music intervention group. These participants will therefore not have an "immersive" experience as they will only hear the music (i.e they will not be able to see the musicians playing). The participants in the music intervention via headband will remain seated during the 15 minutes of the intervention. During the intervention, the research assistant will stay at their side. Should the participant express any discomfort or have any questions/concerns with the intervention, the research assistant will be available and able to answer/assist the participants.

    Other: Music only control

Interventions

  • OtherVirtual reality (VR) music intervention

    The VR music intervention consists of musical performance which were already recorded. This is accessible classic music. During the intervention, the participants will be able to see the musicians (and the stage, empty auditorium, etc.) and hear the music.

  • OtherMusic only control

    The control group consists of the same musical performances, with the audio only

06

What researchers measure

Primary outcomes

  1. Feasibility of the music VR program

    The recruitment goals will be met (n=30) within 6 months, attrition will be ≤ 20% for follow-up. Intervention drop-out will be ≤30% (i.e. fail to attend 50% of the intervention), and VR participants will have \<1 major technical issues

    Time frame: 2 Days

  2. Tolerability of the music VR program

    The intervention will be acceptable and well-tolerated according to the Simulator Sickness Questionnaire (SSQ). The SSQ questionnaire consists of 16 symptoms including fatigue, headache and nausea which are rated from 0 (none) to 4 (severe). Cut-off for tolerability is \< 10 over 64 years of age.

    Time frame: 2 days

  3. Acceptability of the music VR program

    Participants randomized to VR will be willing to use VR again compared to the non-VR group. This means that they will have higher presences, according to the Slater-Usoh-Steed Presence Questionnaire (SUS) score 0-100, i.e. a significantly higher SUS score compared to the non-VR group. The intervention will be acceptable to patients and won't have an impact on the clinical load of the clinical team.

    Time frame: 2 Days

Secondary outcomes

  1. Preliminary efficacy of the VR based music intervention in improving positive emotions

    Compared to the non-VR group, the VR based music group will have a greater improvement in positive emotions using the Visual Analog Mood

    Time frame: 2 Days

  2. Preliminary efficacy of the VR based music intervention in improving pain

    Compared to the non-VR group, the VR based music group will have a greater improvement in pain, using the Visual Analog Pain Scale

    Time frame: 2 days

Other outcomes

  1. preliminary efficacy of the VR based music intervention in improving mental well-being

    Compared to the non-VR group, the VR based music group will have a greater improvement in well-being, anxiety and depression using the Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS)

    Time frame: 2 Days

  2. preliminary efficacy of the VR based music intervention in improving symptoms of anxiety

    Compared to the non-VR group, the VR based music group will have a greater improvement in anxiety using the Generalized Anxiety Disorder-7 scale (GAD-7)

    Time frame: 2 Days

  3. preliminary efficacy of the VR based music intervention in improving symptoms of depression.

    Compared to the non-VR group, the VR based music group will have a greater improvement in depression using the Geriatric Depression Scale (GDS-4)

    Time frame: 2 Days

07

Study locations

1 of 1 sites recruiting
  • St.Mary's Research Centre
    Montréal, Quebec H3T 0A2, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Nov 2024, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2024
First posted
Jul 25, 2024
StartActual
May 22, 2024
Primary completionEst.
Nov 22, 2024
CompletionEst.
May 22, 2025
Last update
Jul 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06519253
Lead sponsor
St. Mary's Research Center, Canada
Responsible party
Harmehr Sekhon, PhD (Assistant Professor and Associate Scientist, St. Mary's Research Center, Canada) — Principal investigator
First posted
Jul 25, 2024
Start date
May 22, 2024
Primary completion
Nov 22, 2024 (estimated)
Completion
May 22, 2025 (estimated)
Last update
Jul 25, 2024

Study contacts

Julia Chabot, MD
Contact
Julia.chabot@mcgill.ca
(514) 345-3511 ext. 5060
Harmehr Sekhon, PhD
Contact
harmehr.sekhon@mcgill.ca
(514) 345-3511 ext. 5060

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion